182 related articles for article (PubMed ID: 11815968)
1. The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma: a multicenter study.
Hefler LA; Concin N; Mincham D; Thompson J; Swarte NB; van Eijkeren MA; Sie-Go DM; Hammond I; McCartney AJ; Tempfer CB; Speiser P
Cancer; 2002 Jan; 94(1):125-30. PubMed ID: 11815968
[TBL] [Abstract][Full Text] [Related]
2. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
Tempfer C; Sliutz G; Haeusler G; Speiser P; Reinthaller A; Breitenecker G; Vavra N; Kainz C
Br J Cancer; 1998 Oct; 78(8):1091-4. PubMed ID: 9792156
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
[TBL] [Abstract][Full Text] [Related]
4. Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinoma.
Tempfer C; Gitsch G; Hanzal E; Reinthaller A; Koelbl H; Kainz C
Anticancer Res; 1996; 16(4A):2029-31. PubMed ID: 8712738
[TBL] [Abstract][Full Text] [Related]
5. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of CD44 variant 6 in laryngeal epidermoid carcinomas.
Güler G; Saraç S; Uner A; Karabulut E; Ayhan A; Hiroshi O
Arch Otolaryngol Head Neck Surg; 2002 Apr; 128(4):393-7. PubMed ID: 11926913
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva.
Tempfer C; Gitsch G; Haeusler G; Reinthaller A; Koelbl H; Kainz C
Cancer; 1996 Jul; 78(2):273-7. PubMed ID: 8674003
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumors: a possible diagnostic tool for the diagnosis of leiomyosarcoma.
Poncelet C; Walker F; Madelenat P; Bringuier AF; Scoazec JY; Feldmann G; Darai E
Hum Pathol; 2001 Nov; 32(11):1190-6. PubMed ID: 11727257
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of CD44 isoform expression in endometrial cancer.
Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C
Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051
[TBL] [Abstract][Full Text] [Related]
10. CD44 is an independent prognostic factor in early-stage cervical cancer.
Speiser P; Wanner C; Tempfer C; Mittelböck M; Hanzal E; Bancher-Todesca D; Gitsch G; Reinthaller A; Kainz C
Int J Cancer; 1997 Apr; 74(2):185-8. PubMed ID: 9133453
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy.
Aaltomaa S; Lipponen P; Viitanen J; Kankkunen JP; Ala-Opas M; Kosma VM
Eur Urol; 2000 Nov; 38(5):555-62. PubMed ID: 11096236
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study.
Ma W; Deng Y; Zhou L
Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):258-63. PubMed ID: 15997921
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma.
Tringler B; Grimm C; Sliutz G; Leodolter S; Speiser P; Reinthaller A; Hefler LA
Gynecol Oncol; 2005 Oct; 99(1):80-3. PubMed ID: 16009408
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
[TBL] [Abstract][Full Text] [Related]
15. CD44v3 and VEGF-C expression and its relationship with lymph node metastasis in squamous cell carcinomas of the uterine cervix.
Liu YQ; Li HF; Han JJ; Tang QL; Sun Q; Huang ZQ; Li HG
Asian Pac J Cancer Prev; 2014; 15(12):5049-53. PubMed ID: 24998585
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of CD44 expression in invasive squamous cell carcinoma of the vulva.
Rodríguez-Rodríguez L; Sancho-Torres I; Miller Watelet L; Gibbon DG; Comerci JT; Mesonero C
Gynecol Oncol; 1999 Oct; 75(1):34-40. PubMed ID: 10502422
[TBL] [Abstract][Full Text] [Related]
17. Significance of immunohistochemical over-expression of CD44v6 as an indicator of malignant potential in esophageal squamous cell carcinoma.
Nozoe T; Kohnoe S; Ezaki T; Kabashima A; Maehara Y
J Cancer Res Clin Oncol; 2004 Jun; 130(6):334-8. PubMed ID: 14872339
[TBL] [Abstract][Full Text] [Related]
18. Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma.
Ayhan A; Baykal C; Al A; Ayhan A
Gynecol Oncol; 2001 Dec; 83(3):569-74. PubMed ID: 11733974
[TBL] [Abstract][Full Text] [Related]
19. [Expression of P53, COX2 and CD44V6 in early-stage squamous carcinoma of cervix with lymph vascular space invasion positive and negative and its relationship with prognosis].
Zhang R; Song Y; Gao WJ; Zhang X; Zuo J; Lei CZ; Wang Y
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3341-5. PubMed ID: 20193563
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer.
Aaltomaa S; Lipponen P; Ala-Opas M; Kosma VM
Eur Urol; 2001 Feb; 39(2):138-44. PubMed ID: 11223672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
